Comprehensive detection of causative pathogens using real-time PCR to diagnose pediatric community-acquired pneumonia

Keiko Hamano-Hasegawa1, Miyuki Morozumi, Eiichi Nakayama

  • 1Kitasato Institute for Life Sciences, Laboratory of Molecular Epidemiology for Infectious Agents, 5-9-1 Shirokane, Minato-ku, Tokyo, 108-8641, Japan.

Insights

A new real-time RT-PCR method accurately detects 13 respiratory viruses and six bacteria in pediatric community-acquired pneumonia (CAP). This diagnostic advance aids in identifying coinfections and guides appropriate antimicrobial use.

Area of Science:

  • Medical Microbiology
  • Virology
  • Pediatric Infectious Diseases

Background:

  • Community-acquired pneumonia (CAP) in children presents diagnostic challenges.
  • Accurate identification of viral and bacterial pathogens is crucial for effective treatment.
  • Coinfections with multiple pathogens can complicate diagnosis and management.

Purpose of the Study:

  • To develop and validate a multiplex real-time RT-PCR assay for simultaneous detection of common respiratory viruses and bacteria.
  • To investigate the prevalence of viral and bacterial etiologies, including coinfections, in pediatric CAP cases.

Main Methods:

  • Development of a real-time reverse transcription-PCR (RT-PCR) assay.
  • Detection of 13 respiratory viruses (Influenza A/B, RSV A/B, PIV 1-3, adenovirus, rhinovirus, enterovirus, coronavirus OC43, hMPV, HBoV).
  • Simultaneous detection of six bacterial pathogens in 1700 pediatric CAP patient samples.

Main Results:

  • Etiology remained unknown in 22.6% of cases.
  • Bacterial infections were suspected in 34.4% (single/multiple), viral infections in 27.9% (single/multiple), and coinfections in 15.2%.
  • Key identified pathogens included Streptococcus pneumoniae (24.4%), Mycoplasma pneumoniae (14.8%), Rhinovirus (14.5%), and RSV (9.4%).

Conclusions:

  • The developed multiplex RT-PCR method enhances diagnostic accuracy for pediatric CAP.
  • This assay facilitates the identification of viral, bacterial, and coinfections.
  • Improved diagnostics can lead to more appropriate antimicrobial prescribing practices.

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Real Time RT-PCR02:57

Real Time RT-PCR

Real-time reverse transcription-polymerase chain reaction, or Real-time RT-PCR, is an analytical tool used to determine the expression level of target genes. The method involves converting mRNA to complementary DNA with the help of an enzyme known as reverse transcriptase, followed by the PCR amplification of the cDNA. These two processes can be performed simultaneously in a single tube or separately as a two-step reaction.
The real-time quantification of the number of amplified products is...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Rapid Identification of Pathogens01:25

Rapid Identification of Pathogens

MALDI-TOF MS has transformed clinical microbiology by offering a rapid and reliable method for pathogen identification. The traditional approach to microbial identification typically involves time-consuming culture techniques and biochemical tests, which can delay the initiation of appropriate antimicrobial therapy. MALDI-TOF MS avoids these delays by using characteristic ribosomal protein mass patterns of microbial cells, enabling accurate species-level identification within minutes.Principle...